ClinicalTrials.gg
RecruitingNCT07787026Updated Aug 26, 2026

Assessing the Short-Term Effects of Multi-Fiber Supplementation on Gut Health

An interventional study of Prebiotic and Placebo in Mixed Fiber Supplementation for Healthy Adults, sponsored by Brown University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-26.

Sponsored by Brown University · Not applicable, Interventional, and Basic science

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a randomized, parallel-group interventional study evaluating the short-term gastrointestinal effects of a standardized multi-fiber supplement in healthy adults. Approximately 100 participants (50 per arm) aged 18 and older will be randomized to receive either the multi-fiber supplement or a control (flavoring agent only) daily for 10 days. Objectives include assessing effects on stool characteristics, specifically frequency and consistency, as well as changes in metagenomically inferred short-chain fatty acid production potential from the microbiota. Eligible participants must be free of chronic disease, acute illness, and recent antibiotic, probiotic, or prebiotic use. Total participation duration is 10 days.

02

Conditions studied

  • Mixed Fiber Supplementation for Healthy Adults

Keywords

  • Dietary fiber
  • Prebiotic
  • Stool regularity
  • Randomized controlled trial
  • Healthy adults
  • Microbiome
  • Microbiota
  • Fiber supplementation
03

In context

Lead sponsor

Brown University is the lead sponsor of 290 studies on the registry; 40 are open to participants now.

Of its 26 completed or terminated interventional studies of FDA-regulated products, 19 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • in self-reported good health (i.e. no chronic disease, no acute illness)

Exclusion criteria

Exclusion Criteria:

  • chronic disease
  • acute illness
  • antibiotic, or probiotic, or prebiotic use in the prior 3 months
  • allergies to any of the following: psyllium husk powder, mustard, sesame, soy, tree nuts, pectin, citric acid, wheat, milk, egg, beta-glucan, barley, inulin, agave, resistant maltodextrin, arabinoxylan
  • adherence to any food-group strict diet (e.g. vegan, vegetarian, keto, etc.)
  • any of the following groups: adults unable to consent, individuals that are not yet adult, pregnant women, prisoners
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Mixed Fiber Supplementation Intervention Arm

    Dietary Supplement: Prebiotic

  • Placebo comparator
    Placebo Supplementation Arm

    Dietary Supplement: Placebo

Interventions

  • Dietary supplementPrebioticsStudies of PrebioticsPrebiotics pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Formulated prebiotic supplement designed to be accessible to gut microbiota members and assist with bowel movement regularity

  • Dietary supplementPlacebo

    Placebo supplementation intervention, with only flavoring agents and no prebiotic fiber

06

What researchers measure

Primary outcomes

  1. Change in metagenomically inferred SCFA production potential

    Through metagenomic sequencing analysis, change in relative abundance of short-chain fatty acid producing genes from sequenced timepoint stool samples will be assessed.

    Time frame: Change observed from baseline sample (Day 0) to second sample (Day 10)

Secondary outcomes

  1. Bowel Movement Regularity

    From a questionnaire that participants will fill out each day of the study, the number of bowel movements, the Bristol stool scale value, and amount of strain experienced during defecation will be assessed.

    Time frame: Change observed over time from baseline (Day 0) through completion of the study (Day 10)

Other outcomes

  1. Observed changes in stool microbiome composition as profiled by metagenomic sequencing analysis

    Statistically significant shifts in composition, diversity, and functionality

    Time frame: Change observed from baseline sample (Day 0) to second sample (Day 10)

07

Study locations

1 of 1 sites recruiting
  • Biomedical Center
    Providence, Rhode Island 02912, United States
    Recruiting
    • BioMed Facilities Planning and Operations · Contactbiomed_facilities@brown.edu · 401-863-1000
    • Peter Belenky, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2026; primary completion for Aug 2028, 24 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 20, 2026
First posted
Aug 26, 2026
StartEst.
Aug 2026
Primary completionEst.
Aug 2028
CompletionEst.
Aug 2029
Last update
Aug 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07787026
Lead sponsor
Brown University
Responsible party
Sponsor
First posted
Aug 26, 2026
Start date
Aug 2026 (estimated)
Primary completion
Aug 2028 (estimated)
Completion
Aug 2029 (estimated)
Last update
Aug 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Prebiotics

Start the discussion